G.O. CLEVELAND, I.V. KLYUCHAROV 

Kazan State Medical University, 49 Butlerova St., Kazan, Russian Federation 420012

Cleveland G.O. — post-graduate student of the department of obstetrics and gynecology № 1,тel. +7-904-764-09-87, e-mail: akridared@yahoo.com

Klyucharov I.V. — Candidate of Medical Science, Assistant professor of the department of obstetrics and gynecology № 1, тel. +7-917-282-44-74, e-mail: klyucharoff@yandex.ru

Extrauterine pregnancy is a common emergency pathology of the female reproductive system, the treatment of which in majority of cases is provided with a surgical approach. In 1982 was for the first time published report of the use of methotrexate to treat extrauterine pregnancy. The practical experience in the treatment of extrauterine pregnancy with methotrexate allowed talking of its high efficiency and security subject to the following indications and application conditions. However, in Russia, the proportion of methotrexate in the treatment of extrauterine pregnancy is 5-8%, while overseas it is 25-33%. The article describes the use of methotrexate to treat extrauterine pregnancy, that have found wide application abroad and is given the analysis of the results of its application.

Key words: extrauterine pregnancy, early stage, nonoperative medicamental, treatment, methotrexate.

REFERENCES

1. Divakova T.S., Sachek Yu.A. Ectopic pregnancy (Etiology, diagnosis, modern concepts of surgical and medical treatment). Vestnik Vitebskogo gosudarstvennogo meditsinskogo universiteta [Bulletin of Vitebsk State Medical University], 2004, vol. 3, no. 2, pp. 5-12. (in Russ.).

2. Strizhakov A.N., Davydov A.I., Shakhlamova M.N., Belotserkovtseva L.D. Vnematochnaya beremennost’ [Ectopic pregnancy]. Moscow, Meditsina Publ., 2001. 215 p.

3. Tanaka T., Hayashi H., Kutsuzawa T., Fujimoto S., Ichinoe K. Treatment of interstitial ectopic pregnancy with methotrexate: Report of a successful case. Fertility and Sterility, 1982, vol. 37, no. 6, pp. 851-852.

4. Tang A., Baartz D., Khoo S.K. A medical management of interstitial ectopic pregnancy: A 5-year clinical study. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2006, vol. 46, no. 2, pp. 107-111. DOI: 10.1111/j.1479-828X.2006.00537.x.

5. Hoover K.W., Tao G., Kent C.K. Trends in the diagnosis and treatment of ectopic pregnancy in the United States. Obstetrics and Gynecology, 2010, vol. 115, no. 3, pp. 495-502. DOI: 10.1097/AOG.0b013e3181d0c328.

6. Lozeau A.M., Potter B. Diagnosis and management of ectopic pregnancy. American Family Physician, 2005, vol. 72, no. 9, pp. 1707-1714.

7. Lecuru F., Bernard J.P., Mac-Cordick C., Boucaya V., Taurelle R. Methotrexate provides significant cost savings for the treatment of unruptured ectopic pregnancy. Clinical Drug Investigation, 1998, vol. 15, no. 5, pp. 405-411.

8. Evans A.T., Niswander K.R. Manual of obstetrics. Philadelphia, Lippincott Williams & Wilkins Publ., 1995. 560 p. (Russ. ed.: Nisvander K., Evans A. Akusherstvo. Spravochnik Kaliforniyskogo universiteta. Moscow, Praktika Publ., 1999. 706 p.).

9. Jermy K., Thomas J., Doo A., Bourne T. The conservative management of interstitial pregnancy. BJOG: An International Journal of Obstetrics and Gynaecology, 2004, vol. 111, no. 11, pp. 1283-1288. DOI: 10.1111/j.1471-0528.2004.00442.x.

10. Ramakrishnan K., Scheid D.C. Ectopic pregnancy: Expectant management or immediate surgery? An algorithm to improve outcomes. Journal of Family Practice, 2006, vol. 55, no. 6, pp. 517-522.

11. Murray H., Baakdah H., Bardell T., Tulandi T. Diagnosis and treatment of ectopic pregnancy. CMAJ: Canadian Medical Association Journal, 2005, vol. 173, no. 8, pp. 905-912. DOI: 10.1503/cmaj.050222.

12. Medical management of ectopic pregnancy. Obstetrics and Gynecology, 2008, vol. 111, no. 6, pp. 1479-1485. DOI:10.1097/AOG.0b013e31817d201e.

13. Tenore J.L. Ectopic pregnancy. American Family Physician, 2000, vol. 61, no. 4, pp. 1080-1088.

14. Medical treatment of ectopic pregnancy. Fertility and Sterility, 2008, vol. 90, no. 5 (suppl.), pp. S206-S212. DOI:10.1016/j.fertnstert.2008.08.049.

15. Barnhart K.T. Clinical practice. Ectopic pregnancy. New England Journal of Medicine, 2009, vol. 361, no. 4, pp. 379-387+334. DOI:10.1056/NEJMcp0810384.

16. Lipscomb G.H., Stovall T.G.., Ling F.W. Primary care: Nonsurgical treatment of ectopic pregnancy. New England Journal of Medicine, 2000, vol. 343, no. 18, pp. 1325-1329. DOI:10.1056/NEJM200011023431807.

17. Nama V., Manyonda I. Tubal ectopic pregnancy: Diagnosis and management. Archives of Gynecology and Obstetrics, 2009, vol. 279, no. 4, pp. 443-453. DOI:10.1007/s00404-008-0731-3.

18. Olofsson J.I., Poromaa I.S., Ottander U., Kjellberg L., Damber M.-G.. Clinical and pregnancy outcome following ectopic pregnancy; a prospective study comparing expectancy, surgery and systemic methotrexate treatment. Acta Obstetricia et Gynecologica Scandinavica, 2001, vol. 80, no. 8, pp. 744-749. DOI: 10.1034/j.1600-0412.2001.080008744.x.

19. Fernandez H., Lelaidier C., Thouvenez V., Frydman R. The use of a pretherapeutic, predictive score to determine inclusion criteria for the non-surgical management of ectopic pregnancy. Human Reproduction, 1991, vol. 6, no. 7, pp. 995-998.

20. Elito J. Jr., Reichmann A.P., Uchiyama M.N., Camano L. Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexate. International Journal of Gynecology and Obstetrics, 1999, vol. 67, no. 2, pp. 75-80. DOI:10.1016/S0020-7292(99)00114-9.

21. Min H.M., Young H.L., Kyung T.L., Jae H.Y., Seong H.P. Outcome prediction for treatment of tubal pregnancy using an intramuscular methotrexate protocol. Journal of Ultrasound in Medicine, 2008, vol. 27, no. 10, pp. 1461-1467.

22. Nazac A., Gervaise A., Bouyer J., de Tayrac R., Capella-Allouc S., Fernandez H. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies. Ultrasound in Obstetrics and Gynecology, 2003, vol. 21, no. 2, pp. 181-185. DOI:10.1002/uog.9.

23. Nguyen Q., Kapitz M., Downes K., Silva C. Are early human chorionic gonadotropin levels after methotrexate therapy a predictor of response in ectopic pregnancy? American Journal of Obstetrics and Gynecology, 2010, vol. 202, no. 6, pp. 630e1-630e5. DOI:10.1016/j.ajog.2010.03.022.

24. Hajenius P.J., Engelsbel S., Mol B.W., Van der Veen F., Ankum W.M., Bossuyt P.M., Hemrika D.J., Lammes F.B. Randomised trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. The Lancet, 1997, vol. 350, no. 9080, pp. 774-779. DOI:10.1016/S0140-6736(97)05487-1.

25. Lehner R., Kucera E., Jirecek S., Egarter C., Husslein P. Ectopic pregnancy. Archives of Gynecology and Obstetrics, 2000, vol. 263, no. 3, pp. 87-92.

26. Barnhart K.T., Gosman G., Ashby R., Sammel M. The medical management of ectopic pregnancy: A meta-analysis comparing “single dose” and “multidose” regimens. Obstetrics and Gynecology, 2003, vol. 101, no. 4, pp. 778-784. DOI:10.1016/S0029-7844(02)03158-7.

27. Hajenius P.J., Mol F., Mol B.W., Bossuyt P.M., Ankum W.M., Van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database of Systematic Reviews (Online), 2007, no. 1, pp. CD000324.

28. Alshimmiri M.M., Al-Saleh E.A., Al-Harmi J.A., AlSalili M.B., Al Adwani A., Ibrahim M.E. Treatment of ectopic pregnancy with a single intramuscular dose of methotrexate. Archives of Gynecology and Obstetrics, 2003, vol. 268, no. 3, pp.181-183.DOI: 10.1007/s00404-002-0357-9.

29. Erdem M., Erdem A., Arslan M., Oc A., Biberoglu K., Gursoy R. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy. Archives of Gynecology and Obstetrics, 2004, vol. 270, no. 4, pp. 201-204.

30. Nieuwkerk P.T., Hajenius P.J., Ankum W.M., Van der Veen F., Wijker W., Bossuyt P.M.M. Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients’ health-related quality of life. Fertility and Sterility, 1998, vol. 70, no. 3, pp. 511-517. DOI: 10.1016/S0015-0282(98)00212-X.

31. Overton C. Prompt diagnosis vital in ectopic pregnancy. The Practitioner, 2008, vol. 252, no. 1704, pp. 32-36.

32. Nieuwkerk P.T., Hajenius P.J., Ankum W.M., Van der Veen F., Wijker W., Bossuyt P.M. Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part II. Patient preferences for systemic methotrexate. Fertility and Sterility, 1998, vol. 70, no. 3, pp. 518-522. DOI:10.1016/S0015-0282(98)00213-1.

33. Yao M., Tulandi T., Kaplow M., Smith A.P. A comparison of methotrexate versus laparoscopic surgery for the treatment of ectopic pregnancy: A cost analysis. Human Reproduction, 1996, vol. 11, no. 12, pp. 2762-2766.

34. Alexander J.M., Rouse D.J., Varner E., Austin J.M. Jr. Treatment of the small unruptured ectopic pregnancy: A cost analysis of methotrexate versus laparoscopy. Obstetrics and Gynecology, 1996, vol. 88, no. 1, pp. 123-127. DOI:10.1016/0029-7844(96)00086-5.

35. Krag Moeller L.B., Moeller C., Thomsen S.G., Andersen L.F., Lundvall L., Lidegaard O., Kjer J.J., et al. Success and spontaneous pregnancy rates following systemic methotrexate versus laparoscopic surgery for tubal pregnancies: A randomized trial. Acta Obstetricia et Gynecologica Scandinavica, 2009, vol. 88, no. 12, pp. 1331-1337. DOI:10.3109/00016340903188912.